Venmax Drugs and Pharmaceuticals share news and announcements
BSE: 531015Pharmaceuticals & BiotechnologySmall Cap
Last close ₹14.48down ₹0.51 (3.40%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹14.99.
52-week range of traded prices to 23 Oct 2026
₹12.71Low, 17 Sep 2026₹31.49High, 3 Dec 2025
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹17 Cr4,053rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Not shown: another business merged into the company on 30 Jun 2026, and the accounts this figure is made of do not include it yet. It returns once accounts of the company as it now is are filed.
- Mergernew accounts awaited
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, BSEVolume. Shares traded on the last trading day.
- 7,037
Venmax Drugs and Pharmaceuticals board meetings
121 filed, newest first. Page 1 of 3.
Aug 2026
24 Aug · Board meeting
Meeting on 31 Aug 2026: annual general meeting3 Aug · Board meeting
Meeting on 7 Aug 2026: quarterly results
May 2026
6 May · Board meeting
Meeting on 14 May 2026: audited results
Mar 2026
Jan 2026
30 Jan · Board meeting
Meeting on 7 Feb 2026: quarterly results
Nov 2025
6 Nov · Board meeting
Meeting on 12 Nov 2025: quarterly results
Sep 2025
3 Sep · Board meeting
Aug 2025
25 Aug · Board meeting
Meeting on 2 Sep 2025: annual general meeting, amalgamation and increase in authorised capital8 Aug · Board meeting
Meeting on 16 Aug 2025
Jul 2025
16 Jul · Board meeting
Meeting on 23 Jul 2025: quarterly results
May 2025
2 May · Board meeting
Meeting on 9 May 2025: audited results and quarterly results
Mar 2025
Feb 2025
3 Feb · Board meeting
Meeting on 8 Feb 2025: quarterly results
Jan 2025
6 Jan · Board meeting
Meeting on 11 Jan 2025: increase in authorised capital, issue of warrants and preferential issue of shares
Oct 2024
30 Oct · Board meeting
Meeting on 11 Nov 2024: quarterly results
Aug 2024
16 Aug · Board meeting
Meeting on 22 Aug 20242 Aug · Board meeting
Meeting on 12 Aug 2024: quarterly results
May 2024
7 May · Board meeting
Meeting on 14 May 2024: audited results
Jan 2024
23 Jan · Board meeting
Meeting on 30 Jan 2024: quarterly results16 Jan · Board meeting
Meeting on 16 Jan 2024
Nov 2023
14 Nov · Board meeting
6 Nov · Board meeting
Meeting on 14 Nov 2023: quarterly results
Aug 2023
Jul 2023
31 Jul · Board meeting
Meeting on 11 Aug 2023: annual general meeting and quarterly results